For 17+ years, ADEEP GROUP has been at the forefront of India's pharmaceutical manufacturing revolution — transforming complex chemistry into high-purity commercial APIs and advanced intermediates for global pharmaceutical markets.
ADEEP GROUP encompasses Adeep Life Sciences Pvt Ltd and Adeep Laboratories Pvt Ltd — two integrated entities united by a singular commitment to pharmaceutical excellence.
To be India's most trusted API and advanced intermediate manufacturer — delivering world-class pharmaceutical chemistry that eliminates critical import dependencies and empowers the global generic drug industry.
To establish ADEEP as a globally recognized, world-class API powerhouse by 2028 — leveraging green biocatalysis, enzymatic innovation, and full vertical integration across the pharmaceutical value chain.
We believe great chemistry drives pharmaceutical progress. Every molecule we manufacture represents an uncompromising commitment to purity, regulatory compliance, and consistent commercial supply for global pharmaceutical formulators. Quality is non-negotiable.
From a single manufacturing unit in Bidar to a multi-site pharmaceutical powerhouse spanning Karnataka, Andhra Pradesh, and Telangana.
The journey begins in Bidar, Karnataka with a clear vision to manufacture high-quality APIs domestically.
Established at Kolhar Industrial Area, Bidar. First commercial API manufacturing operations launched under WHO-GMP standards.
Triple ISO certification achieved — Quality, Environmental, and Occupational Health & Safety management systems fully operational.
ISO certifications established the integrated quality and EHS management framework across all operations.
Establishing ADEEP's central innovation, route design, and advanced analytical research powerhouse.
Dedicated Central R&D facility operationalized in Hyderabad, driving innovative route scouting, process chemistry, green biocatalysis, and ICH-grade analytical research.
Specialized subsidiary entity established at APIIC YSRJ Mega Hub, Kopparthi, Kadapa, dedicated to complex heterocyclic intermediates and chiral building blocks.
Strategic entry into Andhra Pradesh's pharmaceutical corridor with the Kopparthi intermediates hub.
Mega-scale capacity expansion underway to power global multi-ton pharmaceutical supply.
Mega-scale greenfield expansion underway at APIIC Plot 27A, YSRJ Mega Hub, Kopparthi, Kadapa. Adding 1000+ KL upcoming reactor capacity under PLI scheme support.
Flagship commercial API manufacturing facility at Kolhar Industrial Area, Bidar successfully receives prestigious WHO-GMP certification, validating world-class cGMP standards.
Prestigious WHO-GMP regulatory approval validates highest standards of quality, safety, and cGMP compliance.
Guided by pharmaceutical industry veterans with over 100+ years of cumulative expertise spanning API synthesis, advanced R&D, regulatory compliance, and large-scale manufacturing operations.
25+ years spearheading API production, green chemistry, and global strategy. Technical pioneer behind ADEEP's commercial biocatalytic synthesis programs.
30+ years orchestrating large-scale pharmaceutical facilities, infrastructure development, and seamless pan-India raw material supply networks.
26+ years governing day-to-day multi-ton plant operations and global regulatory compliance, maintaining ADEEP's flawless zero-warning-letter audit record.
35+ years in enterprise finance, capital allocation, and corporate growth. Led capital strategies for the Hyderabad plant acquisition and PLI schemes.
Nearly a decade of pharma expertise in marketing, business development, and strategic planning. Oversees cross-functional execution across R&D, new launches, commercial operations, and regulatory compliance.
Our values are embedded into every batch we manufacture, every partnership we form, and every decision we make.
Uncompromising honesty, full transparency, and ethical compliance across all scientific and commercial dealings.
Fostering cutting-edge green chemistry, novel enzymatic pathways, and filing process patents that create sustainable competitive advantages.
Delivering exceptional cGMP & WHO-compliant APIs that consistently surpass international pharmacopoeia requirements.
Prioritizing green enzymatic biocatalysis, reduced hazardous effluents, and Zero Liquid Discharge across all manufacturing sites.
Aligned with India's Make in India & PLI initiatives — eliminating critical API import dependencies to strengthen domestic pharmaceutical sovereignty.
Building long-term collaborative relationships with global pharmaceutical leaders — going beyond transactions to create enduring alliances.
ADEEP GROUP operates through two specialized legal entities, each focused on distinct but complementary aspects of pharmaceutical manufacturing.
The primary commercial manufacturing powerhouse — responsible for large-scale API synthesis, quality control, and global supply chain operations.
A specialized subsidiary focused on high-purity chemical intermediates, chiral building blocks, and contract development manufacturing for complex synthesis.
Whether sourcing APIs, exploring custom synthesis, or strategic partnerships — our commercial team is ready to engage.
